AeskuLab

What AeskuLab does

AeskuLab is the Czech Republic operating entity of Unilabs, a European diagnostics group, and functions as the largest private provider of laboratory diagnostics in the country. The company operates more than 20 laboratories and 80+ sample collection points spanning all 14 Czech regions, performing in excess of 24 million examinations annually across biochemistry, hematology, microbiology, immunology, pathology, and genetics, with additional capacity in forensic and medical genetics. AeskuLab serves four primary customer segments: ambulatory physicians and general practitioners, hospital medical facilities, self-pay patients, and veterinary clinics, with services triggered either by physician referral under Czech public health insurance or by direct self-pay purchase.

The core technology platform is the eLAB electronic laboratory system, which supports test ordering, processing, and result delivery, and functions as the operational backbone for healthcare provider integrations. Distribution spans four channels: a physical collection-point network for in-person sampling, a self-serve appointment booking system for specialized tests such as OGTT (oral glucose tolerance test), a direct B2B referral channel for hospitals and ambulatory doctors, and the Unilabs Online e-commerce platform (cz.lab.online) for self-pay consumers. Recent product activity includes new fitness test offerings and sequential expansion of the urine drug testing menu to include ketamine and kratom.

The revenue model combines public health insurance reimbursement for referred patients (channeled through the SSG ČR partnership with the Union of Health Insurance Companies) with direct out-of-pocket payment from self-pay patients at published price-list rates. The self-pay stream is a deliberate diversification away from payer-cycle exposure, supported by e-commerce enablement. AeskuLab is privately held within the Unilabs group, with no public listing or disclosed funding rounds.

Name

AeskuLab

Legal name

Unilabs

Website

https://aeskulab.cz

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

101–250 employees

Short description

AeskuLab is the Czech Republic arm of Unilabs and the country's largest private laboratory diagnostics provider, operating 20+ laboratories and 80+ collection points to deliver 24M+ annual tests across clinical specialties to physicians, hospitals, self-pay patients, and veterinary clinics.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Veterinary Services (541940)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Clinical laboratory services
• Medical diagnostic testing
• Pathology diagnostics
• Genetic testing services
• Veterinary laboratory diagnostics

Headquarters

HQ city

Prague

HQ country

Czechia

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Testing Services: Provides diagnostic laboratory tests for ambulatory doctors, hospitals, and self-pay patients. Revenue generated from both public health insurance reimbursements (for referred patients) and direct patient payments for self-funded tests.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

AeskuLab operates a clinical laboratory diagnostics platform delivering routine and specialized medical testing services through 20+ laboratories and 80+ collection points across the Czech Republic. The company offers diagnostic examinations across biochemistry, hematology, microbiology, immunology, pathology, and genetics for both human and veterinary medicine. Services are delivered to ambulatory doctors, hospitals, and self-pay patients via physician referrals, a network of physical collection sites, and the Unilabs Online e-shop.

Product overview

AeskuLab/Unilabs operates a comprehensive laboratory diagnostic service platform offering a wide range of medical laboratory tests and examinations. The portfolio includes core diagnostic services across multiple specializations (biochemistry, hematology, microbiology, immunology, pathology, and genetics), complemented by specialized testing services such as oral glucose tolerance testing (OGTT) for diabetes screening, genetic testing, urinary calculi analysis, PSA screening for prostate cancer, and TREC KREC immune system testing. Services are delivered through a network of over 20 laboratories and more than 80 collection points throughout the Czech Republic. Self-paying clients can access tests through the Unilabs Online e-shop platform, while referred patients are served through physician-ordered examinations. Recent additions include urine drug testing (now including ketamine) and fitness testing services.

Differentiator

Problem solved

Functional benefit

Brands

• Unilabs Online: E-shop platform for self-paying customers offering laboratory tests
• Unilabs Genetics
• eLAB

Products and services

• Orální glukózový toleranční test (OGTT) pro těhotné (Oral Glucose Tolerance Test for Pregnant Women) Oral Glucose Tolerance Test for pregnant women, performed between weeks 24-28 of pregnancy to assess the body's response to elevated blood sugar and detect gestational diabetes. The test takes approximately 180 minutes and is free for patients with a physician referral; self-pay patients are charged per the published price list.
• Orální glukózový toleranční test (OGTT) pro ostatní pacienty (Oral Glucose Tolerance Test for Other Patients) Oral Glucose Tolerance Test for non-pregnant patients with physician indication. The test assesses the body's response to elevated blood sugar levels and takes approximately 180 minutes. Free for referred patients; self-pay patients pay per the published price list.
• Unilabs Online E-shop Online e-commerce platform allowing self-paying clients to order laboratory examinations directly. Offers various diagnostic tests including fitness tests and other laboratory services, accessible at cz.lab.online.
• Genetika pod značkou Unilabs (Unilabs Genetics) Genetic testing services under the Unilabs Genetics brand, including specialized genetic examinations and consultations such as clinical genetics appointments (e.g., Ambulance klinického genetika in Brno).
• Močové konkrementy (Urinary Calculi Analysis) Diagnostic analysis service for urinary calculi (kidney stones), accessible via a dedicated online platform.
• Vyšetření PSA pro muže (PSA Testing for Men) Prostate-specific antigen (PSA) testing for men, serving as a preventive screening for prostate cancer.
• Vyšetření TREC KREC (TREC KREC Immune Assessment) Diagnostic examination for immune system assessment using TREC KREC analysis.
• Test na drogy z moči (Urine Drug Test) Urine drug testing package covering multiple substances, with ketamine added to the panel in 2026 and kratom added in June 2026.
• Fitness testy (Fitness Tests) Fitness testing service available to self-paying clients through the Unilabs Online e-shop.

Quantifiable outcome

• 24 million+ examinations per year
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• SSG ČRminorOthersCollaboration with SSG ČR (Svaz zdravotních pojišťoven ČR - Union of Health Insurance Companies of Czech Republic) for partnership in healthcare services.

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

Broad incumbents

• Cerba Healthcare: European leader in clinical pathology and specialty diagnostics with operations across multiple countries, providing overlapping reference/esoteric lab capabilities to AeskuLab though at greater geographic breadth.
• Sonic Healthcare: Global medical diagnostics provider with extensive European laboratory operations, providing a broader incumbent benchmark on lab operating models, specialty testing expansion, and D2C strategy.
• Labcorp: Global clinical laboratory and diagnostics company with broad routine, esoteric, and direct-to-consumer offerings, comparable to AeskuLab in product breadth and payor/provider channel diversification.
• Quest Diagnostics: Global clinical laboratory leader that serves as a strategic benchmark for AeskuLab's routine-to-specialty mix, employer/health-plan contracting models, and consumer-initiated testing (e.g., fitness/preventive panels).
• Eurofins Scientific: European-based testing services group with strong clinical diagnostics and specialty lab offerings, comparable to AeskuLab in laboratory scale and breadth though with a more diversified non-clinical testing portfolio.

Direct peers

• Synlab: Pan-European clinical laboratory operator that competes directly with AeskuLab/Unilabs in the Czech Republic across routine and specialized diagnostic testing, with comparable scale, B2B provider relationships, and D2C channels.
• CityLab: Czech-based clinical laboratory provider offering routine and specialized testing across multiple collection points, directly competing with AeskuLab in the Czech ambulatory and self-pay segments.
• SPADIA Lab: Central European clinical laboratory network with operations in Czech Republic and Slovakia, competing with AeskuLab in hospital and ambulatory diagnostic testing with similar multi-channel distribution.
• AGELLAB (Agel): Czech private laboratory operator owned by Agel that directly competes with AeskuLab in routine and hospital lab services within the Czech market, with overlapping customer base among ambulatory doctors and hospitals.

Regional players

• Medicover: Healthcare services and diagnostics operator active across Central and Eastern Europe including Czech-adjacent markets, offering comparable lab and outpatient diagnostic services with a regional rather than Czech-only focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/UnilabsCesko
• LinkedInlinkedin.com/company/3072377
• Instagraminstagram.com/unilabs_cesko

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AeskuLab